ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 160 filers reported holding ZIOPHARM ONCOLOGY INC in Q4 2020. The put-call ratio across all filers is 1.51 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $79,000 | -46.3% | 121,469 | -10.0% | 0.00% | – |
| Q4 2021 | $147,000 | -36.9% | 134,981 | +5.3% | 0.00% | – |
| Q3 2021 | $233,000 | -41.8% | 128,242 | -15.3% | 0.00% | – |
| Q2 2021 | $400,000 | -32.2% | 151,455 | -7.4% | 0.00% | – |
| Q1 2021 | $590,000 | -25.2% | 163,595 | -47.7% | 0.00% | – |
| Q4 2020 | $789,000 | +6.9% | 313,080 | +6.9% | 0.00% | -100.0% |
| Q3 2020 | $738,000 | -21.3% | 292,956 | +2.4% | 0.00% | 0.0% |
| Q2 2020 | $938,000 | +155.6% | 286,137 | +91.4% | 0.00% | – |
| Q1 2020 | $367,000 | +32.5% | 149,501 | +153.3% | 0.00% | – |
| Q4 2019 | $277,000 | -25.1% | 59,022 | -31.9% | 0.00% | – |
| Q3 2019 | $370,000 | +23.7% | 86,622 | +67.2% | 0.00% | – |
| Q2 2019 | $299,000 | +43.8% | 51,812 | -4.6% | 0.00% | – |
| Q1 2019 | $208,000 | +56.4% | 54,290 | -24.4% | 0.00% | – |
| Q4 2018 | $133,000 | -94.4% | 71,791 | -90.4% | 0.00% | -100.0% |
| Q3 2018 | $2,384,000 | +69.2% | 745,579 | +59.7% | 0.00% | – |
| Q2 2018 | $1,409,000 | -43.4% | 466,893 | -26.6% | 0.00% | -100.0% |
| Q1 2018 | $2,491,000 | +104.9% | 635,744 | +116.0% | 0.00% | 0.0% |
| Q4 2017 | $1,216,000 | +62.3% | 294,287 | +141.1% | 0.00% | 0.0% |
| Q3 2017 | $749,000 | -66.6% | 122,060 | -66.1% | 0.00% | -50.0% |
| Q2 2017 | $2,241,000 | +307.5% | 360,512 | +314.3% | 0.00% | – |
| Q1 2017 | $550,000 | +2.0% | 87,021 | -13.9% | 0.00% | – |
| Q4 2016 | $539,000 | -86.5% | 101,016 | -85.7% | 0.00% | -100.0% |
| Q3 2016 | $3,981,000 | +0.4% | 707,512 | -2.1% | 0.00% | 0.0% |
| Q2 2016 | $3,965,000 | +1580.1% | 722,664 | +2155.5% | 0.00% | – |
| Q1 2016 | $236,000 | -74.2% | 32,040 | -70.9% | 0.00% | -100.0% |
| Q4 2015 | $914,000 | -36.4% | 110,279 | -30.9% | 0.00% | 0.0% |
| Q3 2015 | $1,436,000 | +23.7% | 159,535 | +64.6% | 0.00% | 0.0% |
| Q2 2015 | $1,161,000 | +54.4% | 96,946 | +38.3% | 0.00% | – |
| Q1 2015 | $752,000 | +168.6% | 70,101 | +26.0% | 0.00% | – |
| Q4 2014 | $280,000 | -0.4% | 55,625 | -48.1% | 0.00% | – |
| Q3 2014 | $281,000 | -40.7% | 107,120 | -9.2% | 0.00% | – |
| Q2 2014 | $474,000 | -1.5% | 117,933 | +12.1% | 0.00% | – |
| Q1 2014 | $481,000 | +191.5% | 105,173 | -21.9% | 0.00% | – |
| Q4 2013 | $165,000 | -47.5% | 134,690 | -23.7% | 0.00% | – |
| Q3 2013 | $314,000 | – | 176,603 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 14,013,093 | $9,142,000 | 0.78% |
| MSD Partners, L.P. | 15,151,516 | $9,885,000 | 0.54% |
| MSD Partners, L.P. | 7,575,758 | $4,942,000 | 0.27% |
| CHIRON CAPITAL MANAGEMENT, LLC | 144,960 | $95,000 | 0.06% |
| MAGNOLIA CAPITAL ADVISORS LLC | 185,456 | $121,000 | 0.05% |
| Allred Capital Management, LLC | 128,000 | $83,000 | 0.04% |
| Virtus ETF Advisers LLC | 131,413 | $86,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 232,438 | $152,000 | 0.02% |
| ACT WEALTH MANAGEMENT, LLC | 37,071 | $24,000 | 0.01% |
| Pathway Financial Advisors LLC | 30,000 | $20,000 | 0.01% |